Renee Combs

Renee Combs serves as the primary procurement lead for the W40M MRC0 West agency under the Department of the Army, responsible for managing critical acquisitions that sustain military medical readiness. She oversees the procurement of advanced in-vitro diagnostic substances, analytical laboratory instruments, sterilization systems, and blood management technologies essential for field-deployable, high-acuity care. Her role is central to ensuring operational sovereignty by securing mission-critical medical capabilities that support combat medics and forward surgical teams. Combs manages a diverse portfolio of contracts spanning diagnostic, therapeutic, and laboratory support systems, ensuring timely delivery of equipment and reagents that meet stringent military performance and regulatory standards. Combs maintains long-standing relationships with leading medical technology vendors, including Roche Diagnostics Corporation, Abbott Molecular Inc., Cardinal Health 414, LLC, Surgical Neuromonitoring Associates, Inc., and Premier Shockwave, Inc. These partnerships reflect a preference for established, high-reliability suppliers with proven track records in defense-compliant manufacturing and supply chain resilience. Her contracting approach prioritizes technical validation, regulatory compliance, and logistics readiness, often leveraging indefinite-delivery/indefinite-quantity (IDIQ) and basic ordering agreements to ensure rapid response during operational contingencies. Combs’ procurement portfolio reflects a 100% no set-aside preference, indicating a strategic focus on technical capability and mission-critical performance over socioeconomic categorizations. While small business participation is not formally prioritized in her award patterns, her contracting decisions are driven by the necessity of sourcing products that meet exacting military specifications, often requiring specialized manufacturing capabilities available only from large, established industry leaders. Her primary focus lies in NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing) and 334516 (Analytical Laboratory Instrument Manufacturing), underscoring deep expertise in molecular diagnostics, point-of-care testing systems, and precision laboratory instrumentation. She consistently procures reagents, assay kits, automated analyzers, and sterilization equipment engineered for harsh operational environments, demonstrating specialized knowledge in clinical laboratory technology and defense medical logistics.